Enveric Biosciences stock rose 162.3% to $2.18 during Thursday’s pre-market session. The company’s market cap stands at $5.9 million.
Enveric Biosciences stock rose 162.3% to $2.18 during Thursday’s pre-market session. The company’s market cap stands at $5.9 million.
Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.
